Shop Now Health Supplements Washington, DC—The U.S. Food and Drug Administration (FDA) announced on July 15 that in June warning letters were sent to companies for illegally marketing products containing 7-hydroxymitragynine (7-OH). FDA said the letters reflect “growing concern around novel potent opioid products being marketed to U.S. consumers and...
Read more